DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss
https://www.zacks.com/stock/news/2310255/dexcom-s-dxcm-q2-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-analyst_blog|earnings_article-2310255
Jul 26, 2024 - DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth. Shares fall.
0
DexCom (DXCM) Q2 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/07/25/dexcom-dxcm-q2-2024-earnings-call-transcript/?source=iedfolrf0000001
Jul 25, 2024 - DXCM earnings call for the period ending June 30, 2024.
0
AMN Healthcare (AMN) Unveils ShiftWise Flex Manager Hub App
https://www.zacks.com/stock/news/2303639/amn-healthcare-amn-unveils-shiftwise-flex-manager-hub-app?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2303639
Jul 17, 2024 - AMN Healthcare's (AMN) Manager Hub app, part of the ShiftWise Flex platform, revolutionizes workforce management for healthcare organizations with enhanced mobile capabilities and comprehensive insights.
0
Thermo Fisher (TMO) Strategic Buyouts Aid Amid Macro Issues
https://www.zacks.com/stock/news/2298563/thermo-fisher-tmo-strategic-buyouts-aid-amid-macro-issues?cid=CS-ZC-FT-analyst_blog|zer_report_update-2298563
Jul 09, 2024 - Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
0
Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds
https://www.zacks.com/stock/news/2298539/bruker-brkr-banks-on-end-market-growth-amid-macro-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2298539
Jul 09, 2024 - Bruker's (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.
0
Tandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi
https://www.zacks.com/stock/news/2295786/tandem-diabetes-tndm-posts-positive-data-for-tandem-mobi?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2295786
Jul 01, 2024 - Tandem Diabetes (TNDM) unveils survey results of the new Tandem Mobi insulin delivery system, underscoring its potential to significantly enhance the quality of life for people with diabetes
0
Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System
https://www.zacks.com/stock/news/2291311/insulet-podd-unveils-key-achievements-for-the-omnipod-5-system?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2291311
Jun 21, 2024 - Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.
0
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2289756/why-dexcom-dxcm-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2289756
Jun 18, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
DexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
https://www.zacks.com/stock/news/2284728/dexcom-s-dxcm-g7-cgm-system-now-connects-to-apple-watch?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2284728
Jun 06, 2024 - DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States, the UK, and Ireland.
0
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
https://www.zacks.com/stock/news/2283556/dexcom-dxcm-declines-on-potential-competition-for-stelo-revised?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2283556
Jun 04, 2024 - DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
0